Adenocarcinoma
Studies from University of Halle-Wittenberg yield new data on adenocarcinoma
Published in Gene Therapy Weekly, November 12th, 2009
"Transforming growth factor-beta 1 (TGF-beta 1) is over-expressed in a variety of malignant epithelial tumors and was suggested to be a marker of colorectal cancer. Moreover, there is growing evidence that TGF-beta 1 contributes to tumor progression by regulating tumor cell proliferation and differentiation, inducing a favorable tumor microenvironment, promoting migration and invasion, and suppressing macrophage cytotoxicity," scientists in Halle, Germany report.
"Therefore, we stably transfected an anti-TGF-beta 1 hammerhead ribozyme into the human colorectal adenocarcinoma cell line HRT-18. Expression of this ribozyme resulted in significant inhibition of TGF-beta 1...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2009-11-12)
More Articles from Gene Therapy Weekly
- University of Nevada, Reno
Sanford Barsky, M.D., University of Nevada School of Medicine and Nevada Cancer Institute faculty member publishes scientific paper in the journal Nature - Angiotensins
Research findings from Ohio State University update understanding of angiotensins - Antibiotics
Scientists at Harvard University, Medical Department report research in antibiotics - Breast Cancer
Research on breast cancer described by scientists at University of Tokyo - Cancer
Research by Z. Zhang and colleagues in cancer provides new insights - Cancer
Researchers from University of Rostock provide details of new studies and findings in the area of cancer - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
